BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 23, 2016
View Archived Issues
Merck describes promising adenosine receptor A2a antagonists for treating Parkinson's disease
Read More
DS Biopharma spins out new company Afimmune
Read More
Exosomes encapsulating Alzheimer's disease biomarkers can be detected in plasma
Read More
Regeneron Pharmaceuticals signs agreement with BARDA for MERS research
Read More
AstraZeneca discloses potent capsid-binding human rhinovirus inhibitor AZN-001
Read More
European Commission grants marketing authorization to Gilead's Truvada
Read More
Pfizer set to acquire Medivation
Read More
Final phase IIa trial results for the first topical gel formulation of minocycline, BPX-01
Read More
Novel MST1/2 inhibitor stimulates tissue repair and regeneration in vivo
Read More
FORMA Therapeutics discloses ubiquitin hydrolase inhibitors
Read More
Gilead begins phase III program for filgotinib in rheumatoid arthritis
Read More
Trillium Therapeutics patents EGFR inhibitors
Read More
Novo Nordisk divulges neuropeptide Y receptor agonists
Read More
Sanford-Burnham Medical Research Institute reports glucocorticoid receptor translocation inhibitors
Read More
Emmaus will submit NDA to the FDA for its sickle disease therapy
Read More
VBI Vaccines will continue enrollment on its phase I trial evaluating cytomegalovirus vaccine
Read More
FDA grants fast track designation to AZD-3293 for the treatment of Alzheimer's disease
Read More
Amylyx Pharmaceuticals completes USD 5 million series A financing round
Read More
EMA validates marketing authorization for Puma's neratinib
Read More
Intelgenx completes study of montelukast using the Versafilm delivery technology
Read More
Phase II results for vemurafenib in patients with BRAF[V600E]-positive papillary thyroid cancer
Read More
FORMA Therapeutics patents HDAC 6 inhibitors
Read More
